Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
3,332
-1,485
-31% -$174K 0.4% 86
2026
Q1
$547K Sell
4,817
-132
-3% -$15.2K 0.52% 64
2025
Q4
$521K Buy
+4,949
New +$465K 0.56% 56

Other funds holding MRK

Expressive Wealth's MRK Position: Q2 2026 in Review

Expressive Wealth reduced its Merck (MRK) stake by 31% in Q2 2026, selling an estimated $174K and leaving 3,332 shares worth $428K. The position accounts for 0.4% of the portfolio, ranked #86.

Expressive Wealth first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $547K in Q1 2026. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Expressive Wealth held 3,332 shares of Merck worth $428K as of Q2 2026.
  • Expressive Wealth sold 1,485 Merck shares in Q2 2026, an estimated $174K.
  • Merck made up 0.4% of Expressive Wealth's portfolio in Q2 2026, its #86 holding.
  • Expressive Wealth first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Expressive Wealth's Merck position peaked at $547K in Q1 2026.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Expressive Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.